Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News NY Valves 2024

Leaks After LAAO Do Matter, Experts Agree

Todd Neale

June 10, 2024

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Industry News

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

July 27, 2021

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News EuroPCR 2018

European Consortium Seeks to Increase the Role of Cardiologists in Acute Ischemic Stroke Care

Yael L. Maxwell

June 05, 2018

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

L.A. McKeown

September 15, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

News Conference News VIVA 2016

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

L.A. McKeown

September 21, 2016

News Daily News

El Bajo Consumo de Fruta en China e asocia a un Mayor Riesgo de Muerte Cardiovascular y ACV

Caitlin E. Cox

April 11, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

L.A. McKeown

December 14, 2015

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

L.A. McKeown

December 14, 2015

Advertisement

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Leaks After LAAO Do Matter, Experts Agree

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

New Carotid Stent Systems Associated With Low Stroke Risk

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

New study finds both components of blood pressure predict heart attack, stroke risk

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

European Consortium Seeks to Increase the Role of Cardiologists in Acute Ischemic Stroke Care

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

El Bajo Consumo de Fruta en China e asocia a un Mayor Riesgo de Muerte Cardiovascular y ACV

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content